ACTRN12620000650998
Active, Not Recruiting
N/A
A pilot study to evaluate the benefit of intensive lifestyle intervention (low calorie diet and exercise) with or without bariatric (weight-reduction) surgery in high-risk adolescents with morbid obesity.
Aotearoa Clinical Trials0 sites20 target enrollmentJune 5, 2020
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Aotearoa Clinical Trials
- Enrollment
- 20
- Status
- Active, Not Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Be aged between 15 years 9 months and 18 years inclusive
- •2\.Have been diagnosed with morbid obesity defined as a body mass index (BMI) \>35 kg/m2 at the baseline visit.
- •3\.Have pre\-diabetes or type 2 diabetes mellitus as confirmed by oral glucose tolerance test at the baseline visit.
- •4\.Provide written informed consent to participate in the study
Exclusion Criteria
- •1\.History of type 1 diabetes defined as age of onset \<20 years and/or history of continuous treatment with insulin since diagnosis and/or positive antibodies to glutamic acid decarboxylase \[GAD] or islet tyrosine phosphatase 2 \[IA2] at baseline.
- •2\.History of drug or alcohol abuse
- •3\.Pregnancy
- •4\.Serious co\-morbid conditions that are likely to affect survival
- •5\.Any other disease or condition which in the opinion of the investigator could make them unsuitable for entry.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Exploring potential benefit of earlier nutritional interventions in adults with upper gastrointestinal cancer: a randomised trialOesophageal cancerStomach cancerCancer - Oesophageal (gullet)Cancer - StomachACTRN12611000005954Mary Anne Silvers50
Completed
N/A
Efficacy of a one-week overcoming shyness programSocial Anxiety DisorderMental Health - AnxietyACTRN12620000135910niversity of New South Wales17
Active, Not Recruiting
Phase 1
Study to evaluate the efficacy of OnabotulinumtoxinA in migraineEUCTR2017-002866-38-ITIRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO42
Recruiting
N/A
A Pilot Study of Intensive Supplemental Insulin Therapy: Novorapid vs ActrapidACTRN12608000402347W Cheung24
Not Yet Recruiting
N/A
Estimation of type of hearing loss using a new Forehead knuckle tapping methodCTRI/2021/01/030777Dr Prem Sagar